Biotech

All Articles

ReNeuron leaving objective swap after missing fundraising objective

.ReNeuron has joined the long listing of biotechs to leave behind London's purpose stock market. The...

MBX apply for IPO to take opposition to Ascendis right into phase 3

.MBX Biosciences has actually contributed to the current spurt of IPO filings. The biotech, which fi...

FDA broadens probe right into Lykos' MDMA tests: WSJ

.For Lykos Therapies and also the company's prospective MDMA-assisted therapy for post-traumatic str...

Gene editor Tome laying off 131 employees

.Only times after genetics editor Volume Biosciences declared unrevealed working cuts, a clearer ima...

Repare gives up 25% of team as biotech stops preclinical R&ampD

.Repare Therapeutics is laying off a quarter of its own workforce as the oncology biotech lessen its...

J &amp J apply for FDA confirmation of $6.5 B autoimmune medication

.Johnson &amp Johnson has actually gotten one more step towards realizing a yield on its own $6.5 bi...

Gain's period 1 gain paves technique to confirm Parkinson's drug's worth

.Gain Rehabs has actually set its direct proving the efficiency of its Parkinson's ailment therapy f...

Actinogen documents brand new stage 2 data to save anxiety medicine

.Actinogen Medical's chances-- and inventory rate-- have recoiled slightly from previously this mont...

Pfizer and also Flagship add Ratio to multibillion-dollar formula

.Flagship Pioneering as well as Pfizer have added Quotient into their 10-program relationship, inkin...

Bayer markers $547M treaty to press borders of noncoding RNA

.Bayer execs were actually eager to tension to Strong this summertime that the German pharma giant's...